Senior Research Fellow, NHMRC Emerging Leader Investigator Michelle Tye
Senior Research Fellow, NHMRC Emerging Leader Investigator

The intravenous injection of drugs intended for oral use can cause pulmonary granulamatosis. This project aims to determine the number of cases of sudden or unnatural deaths in which pulmonary granulamatosis was diagnosed, and the medical consequences of pulmonary granulamatosis.

Project Collaborators External

  • Professor Johan Duflou Department of Forensic Medicine, Sydney South West Area Health Service; UNSW; University of Sydney

Project Supporters

Australian Government Department of Health; NSW Health

The injection of tablet preparations has increased markedly in recent years. Such behaviours may result in particles of tablet preparations becoming lodged in the pulmonary vasculature, which may result in pulmonary hypertension and heart failure.

  1. Determine the number of cases of sudden or unnatural deaths in which pulmonary granulamatosis was diagnosed
  2. Determine the medical consequences of pulmonary granulamatosis

Design and Method

Case series. All cases presenting to the New South Wales Department of Forensic Medicine between 1997-2013 were retrieved in which pulmonary granulamatosis was diagnosed.

Benefits

Novel data on the medical consequences of injecting tablets.

Darke, S., Duflou, J. & Torok, M. (2015) The health consequences of injecting tablet preparations: foreign body pulmonary embolization and pulmonary hypertension amongst deceased injecting drug users. Addiction, 110, 1144-1151.

Expected date of completion
-
Project Area
Mortality and Morbidity
Project Contact
Professor Shane Darke
Project Status
Completed
Date Commenced
2013
Year Completed
2015